Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2010-01-11 17:40 |
VIVALIS ANNOUNCES THE STRATEGIC ACQUISITION OF HUMALYS AND THE ADDITION OF A NE…
|
English | 126.9 KB | ||
| 2010-01-08 17:45 |
VIVALIS : DECLARATION ACTIONS ET DROITS DE VOTE
|
French | 7.5 KB | ||
| 2009-12-22 17:40 |
VIVALIS : SIGNATURE D'UNE NOUVELLE LICENCE COMMERCIALE
|
French | 94.0 KB | ||
| 2009-12-07 17:45 |
Déclaration de droits de vote novembre 2009
|
French | 7.5 KB | ||
| 2009-12-01 17:45 |
VIVALIS INTEGRE LES INDICES SBF 250 ET CAC SMALL 90 DE NYSE EURONEXT
|
French | 81.8 KB | ||
| 2009-11-04 17:40 |
VIVALIS : DECLARATION D'ACTIONS ET DROIT DE VOTE
|
French | 7.5 KB | ||
| 2009-10-27 17:45 |
VIVALIS ETEND SON ACCORD AVEC SANOFI-AVENTIS DANS LES PROTEINES THERAPEUTIQUES
|
French | 93.1 KB | ||
| 2009-10-21 17:45 |
VIVALIS CONFIRME SA SOLIDITE FINANCIERE AU TROISIEME TRIMESTRE 2009
|
French | 95.2 KB | ||
| 2009-10-13 17:45 |
VIVALIS ACCELERE LE MARKETING DE LA LIGNEE CELLULAIRE EB66 EN AMERIQUE DU NORD
|
French | 83.1 KB | ||
| 2009-10-09 12:51 |
VIVALIS : RAPPORT SEMESTRIEL 30 JUIN 2009
|
French | 2.0 MB | ||
| 2009-10-05 17:40 |
DECLARATION D'ACTIONS ET DE DROITS DE VOTE
|
French | 7.4 KB | ||
| 2009-09-29 17:40 |
VIVALIS : GSK ET KAKETSUKEN CO-DEVELOPPERONT DES VACCINS ANTI-GRIPPE SUR LIGNEE…
|
French | 103.7 KB | ||
| 2009-09-14 17:40 |
PARTICIPATION AU MIDCAP EVENT A PARIS
|
French | 85.5 KB | ||
| 2009-09-08 17:40 |
VIVALIS NOMME PHILIPPE ROUSSEAU EN TANT QUE DIRECTEUR ADMINISTRATIF ET FINANCIER
|
French | 82.1 KB | ||
| 2009-09-08 17:40 |
VIVALIS APPOINTS PHILIPPE ROUSSEAU AS CHIEF FINANCIAL OFFICER
|
English | 81.7 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
